Malignant Mesenchymal Neoplasms Flashcards

1
Q

What oral path lesion is described below?

“malignancy of fibroblastic differentiation”

A

fibrosarcoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How common is fibrosarcoma? What age group is most affected?

A
  • once among the most common soft tissue sarcomas, but not less frequent due to improved subclassification
  • adults
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the clinical appearance of fibrosarcoma. Histology?

A
  • may present as a soft tissue mass or as an intrabony lesion
  • note: histology has a “herring bone” pattern; highly cellular proliferation, lots of mitotic figures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the recommended treatment for fibrosarcoma?

A
  • wide to radical surgical excision; little response to radiation/chemotherapy, similar to many soft tissue sarcomas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the prognosis of fibrosarcoma? Recurrence? 5-year survival? Metastasis?

A
  • 50% recurrence
  • 40-70% 5-year survival
  • metastasizes to lung, bone, liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What oral path lesion is also known as neurogenic sarcoma?

A

malignant peripheral nerve sheath tumor

note: malignancy of schwann cell differentiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the 2 causes of malignant peripheral nerve sheath tumor? What age groups are affected by each?

A
  • spontaneously (around 5th decade)

- associated with neurofibromatosis, type 1 (around 4th decade)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the histology of malignant peripheral nerve sheath tumors.

A
  • invasive cellular proliferation of spindle-shaped cells with wavy nuclei
  • similar appearance with routine hematoxylin and eosin-stained sections to several other tumors
  • usually shows S100+ by IHC (S100 proteins are marker for neural tissue)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the recommended treatment for malignant peripheral nerve sheath tumors?

A
  • radical surgical excision +/- chemotherapy or radiation therapy
  • overall 50% 5-year survival and 35% 10-year survival
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What oral path lesion was first described as a disease in elderly white males of Mediterranean descent?

A

kaposi sarcoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What oral path lesion is a malignancy of the blood vessels? This is caused by infection of ___.

A
  • karposi sarcoma

- HHV-8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the 4 types of karposi sarcoma?

A
  • classic
  • endemic (african)
  • iatrogenic (transplant associated)
  • epidemic (AIDS-related)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Where does classic karposi sarcoma usually present? What does it look like clinically?

A
  • lower extremities of older adult males; oral involvement uncommon
  • initially purple cutaneous macules that gradually develop into plaques and tumors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What age range is most at risk for endemic (African) karposi sarcoma? What sites can it become involved in?

A
  • affects wide age range of patients, including children
  • widely varied course, from indolent to aggressive
  • lymph nodes and viscera involved in lymphadenopathic form (poor prognosis!)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What sites are affected with iatrogenic (transplant-associated) karposi sarcoma? How can it be treated?

A
  • usually affects the skin of a small percentage (
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What category of patients are most affected by epidemic (AIDS-related) karposi sarcoma? How common is it? What is the most common site?

A
  • predominantly in gay or bisexual men; rarely in women

- frequency has declined from 25% to

17
Q

What is the recommended treatment for karposi sarcoma?

A
  • excision for small cosmetically unacceptable lesions
  • radiation therapy for skin lesions
  • systemic chemotherapy or intralesional injections with anti-cancer agents (vinblastine)
18
Q

What is the prognosis for each type of karposi sarcoma?

A
  • CLASSIC: fair (patients usually die of something else)
  • ENDEMIC: variable (lymphadenopathic form has poor prognosis)
  • IATROGENIC: fair to poor (lesions may regress with reduction in immunosuppressive therapy)
  • AIDS-RELATED: fair
19
Q

What oral path lesion is described below?

“relatively uncommon malignancy of skeletal muscle”

A

rhabdomyosarcoma

20
Q

What age group is most affected by rhabdomyosarcoma? What sites?

A
  • children and adolescents (50% of childhood soft tissue sarcomas)
  • head and neck involvement is common (35%)
21
Q

What is the clinical appearance of rhabdomyosarcoma?

A
  • infiltrative rapidly growing mass
  • when rhabdomyosarcoma grows into body cavity (like oral cavity), lesion may appear similar to a bunch of grapes (called “sarcoma botyoides”)
22
Q

Describe the histology of rhabdomyosarcoma.

A
  • rounded spindle cells with a large nuclei
  • may have strap cells (skeletal muscle differentiation)
  • immunohistochemistry will show skeletal muscle (desmin stain)
23
Q

What is the recommended treatment of rhabdomyosarcoma? Prognosis?

A
  • wide surgical excision combined with radiation therapy and multi-agent chemotherapy
  • prognosis depends on stage and subtype; 5-year survival ranges 44-72%